Observational Study
Copyright ©The Author(s) 2017.
World J Nephrol. Sep 6, 2017; 6(5): 236-242
Published online Sep 6, 2017. doi: 10.5527/wjn.v6.i5.236
Table 3 Quality of life data presented as pool data and divided in two groups according to restless legs syndrome diagnosis
VariablesPatients pool dataRLSNon-RLSP value
SF-36 MCS55.3 ± 16.746.6 ± 15.458.5 ± 16.10.004
95%CI51.6 to 59.039.8 to 53.554.3 to 62.7
SF-36 PCS51.8 ± 19.440.6 ± 18.156.1 ± 18.20.001
95%CI47.5 to 56.132.5 to 48.651.2 to 60.8
SF-36 total score55.1 ± 18.845.5 ± 17.758.7 ± 18.10.004
95%CI51.0 to 59.337.6 to 53.354.0 to 63.4
Physical function46.9 ± 29.138.4 ± 28.250.1 ± 29.10.107
95%CI40.5 to 53.425.8 to 50.942.5 to 57.7
Role physical45.3 ± 42.428.4 ± 38.851.6 ± 42.20.027
95%CI35.9 to 54.711.2 to 45.640.6 to 42.7
Body pain72.3 ± 23.163.9 ± 24.375.4 ± 22.00.045
95%CI67.1 to 77.453.1 to 74.769.6 to 81.1
General health47.0 ± 16.437.1 ± 14.550.7 ± 15.60.001
95%CI43.4 to 50.630.6 to 43.546.6 to 54.8
Vitality48.3 ± 16.136.1 ± 14.552.8 ± 14.20
95%CI44.7 to 51.829.6 to 42.549.1 to 56.6
Social functioning71.8 ± 20.865.5 ± 21.774.1 ± 20.20.098
95%CI67.2 to 76.455.9 to 75.168.9 to 79.4
Mental health52.2 ± 45.343.9 ± 47.555.3 ± 44.40.316
95%CI42.2 to 62.322.8 to 65.043.7 to 66.9
Reported health57.1 ± 12.150.7 ± 10.759.5 ± 11.80.003
95%CI54.4 to 59.845.9 to 55.456.4 to 62.6